Michael C. Petriello

Dr. Michael C. Petriello

Department of Pharmacology, Institute of Environmental Health Sciences, Wayne State University,6135 Woodward Avenue, Ibio 2128, Detroit, MI 48202, USA
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2021 in Environment International
Verified
Journal Article
Open access
KRKatherine Roth
Katherine Roth
ZYZhao Yang
Zhao Yang
MAManisha Agarwal
Manisha Agarwal
WLWendy Liu
Wendy Liu
ZPZheyun Peng
Zheyun Peng
Michael C. PetrielloMichael C. Petriello
Michael C. Petriello
Epidemiological studies have shown Per- and polyfluoroalkyl substances (PFAS) to be associated with diseases of dysregulated lipid and sterol homeostasis such as steatosis and cardiometabolic disorders. However, the majority of mechanistic studies rely on single chemical exposures instead of identifying mechanisms related to the toxicity of PFAS mixtures. The goal of the current study is to investigate mechanisms linking exposure to a PFAS mixture with alterations in lipid metabolism, including increased circulating cholesterol and bile acids. Male and female wild-type C57BL/6J mice were fed an atherogenic diet used in previous studies of pollutant-accelerated atherosclerosis and exposed to water containing a mixture of 5 PFAS representing legacy, replacement, and emerging subtypes (i.e., PFOA, PFOS, PFNA, PFHxS, and GenX), each at a concentration of 2 mg/L, for 12 weeks. Changes at the transcriptome and metabolome level were determined by RNA-seq and high-resolution mass spectrometry respectively. We observed increased circulating cholesterol, sterol metabolites, and bile acids due to PFAS exposure, with some sexual dimorphic effects observed. PFAS exposure increased hepatic injury, demonstrated by increased liver weight, hepatic inflammation, and plasma alanine aminotransferase levels. Females displayed increased lobular and portal inflammation compared to the male PFAS-exposed mice. Hepatic transcriptomics analysis revealed PFAS exposure modulated multiple metabolic pathways, including those related to sterols, bile acids, and acyl carnitines, with multiple sex-specific differences observed. Finally, we show that hepatic and circulating levels of PFOA were increased in exposed females compared to males, but this sexual dimorphism was not the same for other PFAS examined. Exposure of mice to a mixture of PFAS results in PFAS-mediated modulation of cholesterol levels, possibly through disruption of enterohepatic circulation.

17 April 2015 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
JPJordan T. Perkins
Jordan T. Perkins
Michael C. PetrielloMichael C. Petriello
Michael C. Petriello
BNBradley J. Newsome
Bradley J. Newsome
BHBernhard Hennig
Bernhard Hennig

4 December 2020 in Frontiers in Toxicology
Verified
Journal Article
Open access
PDF file
KRKatherine Roth
Katherine Roth
ZIZunaira Imran
Zunaira Imran
WLWanqing Liu
Wanqing Liu
Michael C. PetrielloMichael C. Petriello
Michael C. Petriello
Per- and polyfluoroalkyl substances (PFAS) are ubiquitously found in the environment due to their widespread commercial use and high chemical stability. Humans are exposed primarily through ingestion of contaminated water and food and epidemiological studies over the last several decades have shown that PFAS levels are associated with adverse chronic health effects, including cardiometabolic disorders such as hyperlipidemia and non-alcoholic fatty liver disease. Perhaps the most well-established effects, as demonstrated in animal studies and human epidemiological studies, are the metabolic alterations PFAS exposure can lead to, especially on lipid homeostasis and signaling. This altered lipid metabolism has often been linked to conditions such as dyslipidemia, leading to fatty liver disease and steatosis. Western diets enriched in high fat and high cholesterol containing foods may be an important human exposure route of PFAS and may also act as an important modulator of associated toxicities. In fact, the chemical structure of PFAS resemble fatty acids and may activate some of the same signaling cascades critical for endogenous metabolism. In this review we aim to outline known dietary exposure sources of PFAS, describe the detrimental metabolic health effects associated with PFAS exposure, and focus on studies examining emerging interaction of dietary effects with PFAS exposure that further alter the dysregulated metabolic state.

5 August 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
KRKatherine Roth
Katherine Roth
Michael C. PetrielloMichael C. Petriello
Michael C. Petriello
Per- and polyfluoroalkyl substances (PFAS) are ubiquitous man-made chemicals found in consumer products including fabrics, food packaging, non-stick coatings, and aqueous film-forming foams. PFAS are stable and extremely resistant to degradation, resulting in high persistence throughout the environment as well as in human blood. PFAS consist of a large family of synthetic chemicals, with over 4000 distinct varieties having been identified and around 250 currently being manufactured at globally relevant levels. Numerous epidemiological studies have linked exposure to PFAS with adverse health effects ranging from immunotoxicity, cardiometabolic disease, developmental and reproductive effects, cancer, and recently type 2 diabetes. Several studies have demonstrated associations between serum PFAS concentrations and glycemic indicators of type 2 diabetes including glucose, insulin, and HOMA-IR in adolescent and adult cohorts. In addition, some studies have shown positive associations with incident type 2 diabetes and multiple PFAS. However, the link between PFAS exposure and the development of diabetes continues to be a disputed area of study, with conflicting data having been reported from various epidemiological studies. In this mini review we will summarize the current state of the literature linking PFAS to type 2 diabetes and discuss important future directions including the use of more complex mixtures-based statistical analyses.

1 February 2014 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
BNBradley J. Newsome
Bradley J. Newsome
Michael C. PetrielloMichael C. Petriello
Michael C. Petriello
SHSung Gu Han
Sung Gu Han
MMMargaret O. Murphy
Margaret O. Murphy
KEKatryn E. Eske
Katryn E. Eske
BHBernhard Hennig
Bernhard Hennig

1 December 2015 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
DLDandan Liu
Dandan Liu
JPJordan T. Perkins
Jordan T. Perkins
Michael C. PetrielloMichael C. Petriello
Michael C. Petriello
BHBernhard Hennig
Bernhard Hennig